ABSTRACT:The self-assembly of the amyloid beta (Aβ) peptides into senile plaques is the hallmark of Alzheimer's disease. Recent experiments have shown that the English familial disease mutation (H6R) speeds up the fibril formation process of alloforms Aβ 40 and Aβ 42 peptides altering their toxicity to cells. We used all-atom molecular dynamics simulations at microsecond time scales with the OPLS-AA force field and TIP4P explicit water model to study the structural dynamics of the monomer and dimer of H6R sequences of both peptides. The reason behind the self-assembly acceleration is common that upon mutation the net charge is reduced leading to the weaker repulsive interaction between chains that facilitates the peptide association. In addition, our estimation of the solvation free energy shows that the mutation enhances the hydrophobicity of both peptides speeding up their aggregation. However, we can show that the acceleration mechanisms are different for different peptides: the rate of fibril formation of Aβ 42 increases due to increased β-structure at the C-terminal in both monomer and dimer and enhanced stability of salt bridge Asp23-Lys28 in monomer, while the enhancement of turn at residues 25−29 and reduction of coil in regions 10−13, 26−19, and 30−34 would play the key role for Aβ 40 . Overall, our study provides a detailed atomistic picture of the H6R-mediated conformational changes that are consistent with the experimental findings and highlights the important role of the N-terminal in Aβ peptide aggregation. KEYWORDS: Amyloid simulations, Alzheimer's disease, amyloid-β proteins, molecular dynamics, H6R mutation, monomer, dimer A lzheimer's disease (AD) is a type of dementia that causes problems with memory, thinking, and behavior mainly among the senior population.1 The etiology of AD is complex, but the prominent amyloid cascade hypothesis posits that the deposition of the amyloid beta (Aβ) peptide in the brain parenchyma is a crucial step that ultimately leads to AD.2−4 Evidence accumulated during last years shows that neither mature fibrils nor monomers of Aβ peptides are toxic but the aesthetic of the cerebral defects in AD rather correlates with high levels of oligomers in the brain. 5,6 This leads to the strategy to cope with AD that is based on preventing or reversing formation of toxic oligomers. 2,3,7−15 It is well-known that mutations can alter the toxicity, assembly, and rate of fibril formation of Aβ peptides. Since the turn region 21−23 of Aβ peptides might play a crucial step in fibril formation, numerous experimental 16−21 as well as theoretical 22−28 studies have been performed for various mutations in this region including the Flemish (A21G), Dutch (E22Q), Italian (E22K), Arctic (E22G), Iowa (D23N), and Osaka (ΔE22, deletion) variants. On the other hand, the regions 1−8 of Aβ 40 and 1−16 of Aβ 42 were believed to be disordered in the fibril state, 29−31 and the mutation in the N-terminal has attracted little attention of researchers. However, recent experiments 32−34 have suggest...